Reviva Pharmaceuticals
RVPH
RVPH
3 hedge funds and large institutions have $3.15M invested in Reviva Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-10
Holders Change %
-76.92%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
1
Increased
1
Reduced
1
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.13M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.8K |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$8.78M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$7.63M |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$5.17M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$3.17M |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2.6M |
